
ICHS Symposium Program
Scientific Program - please note that this agenda is subject to change.
ICHS Preliminary Program and Faculty
Up to 18 hours of Physican and Pharmacist credits may be available.
Meet the Keynote Speaker:

Katy Rezvani, MD, PhD, FRCP, FRCPath
VP & Head, Institute for Cellular Therapy
Professor of Medicine
Chief, Section of Cellular Therapy, Department of Stem Cell Transplant and Cellular Therapy
The University of Texas MD Anderson Cancer Center
Houston, Texas USA
Katy Rezvani, MD, PhD is a professor of medicine at the University of Texas MD Anderson Cancer Center, where she serves as the Vice President & Head, Cell Therapy Institute for Discovery and Innovation, Sally Cooper Murray Chair in Cancer Research, and medical director of the GMP Facility. She leads a research lab with a focus on NK cell biology and developing novel NK cell engineering strategies for cancer, with the aim of translating these discoveries to the clinic.
Dr. Rezvani completed her medical training at University College London, England and her PhD at Imperial College London. She completed her training in immunology and transplantation biology at the National Institutes of Health, Bethesda, MD. In addition, she has co-authored over 250 peer-reviewed publications and received multiple prizes and awards, including the American Society of Hematology E. Donnall Thomas award.
For more information on this pioneering work transforming the landscape of immunotherapy please visit:
Katy Rezvani | MD Anderson Cancer Center and Katy Rezvani receives 2023 ASH Honorific Award | MD Anderson Cancer Center